Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 9/20 | 0.85 |
| ▸ | PGR | P06401 | 8/20 | 0.85 |
| ▸ | USP2 | O75604 | 7/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.85 |
| ▸ | LMNA | P02545 | 4/20 | 0.85 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.85 |
| ▸ | CNR1 | P21554 | 3/20 | 0.85 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.85 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.85 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.85 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | MLNR | O43193 | 1/20 | 0.49 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.49 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11584724 | 1.00 | NR3C1 (0.85) | NR3C1PGRUSP2CYP3A4LMNA | |
| SCHEMBL11584722 | 1.00 | NR3C1 (0.85) | NR3C1PGRUSP2CYP3A4LMNA | |
| SCHEMBL14339625 | 1.00 | NR3C1 (0.85) | NR3C1PGRUSP2CYP3A4LMNA | |
| SCHEMBL11584348 | 0.94 | NR3C1 (0.75) | NR3C1PGRUSP2CYP3A4LMNA | |
| SCHEMBL11584350 | 0.94 | NR3C1 (0.75) | NR3C1PGRUSP2CYP3A4LMNA | |
| SCHEMBL11584191 | 0.94 | USP2 (0.85) | NR3C1PGRUSP2CYP3A4LMNA | |
| SCHEMBL11584194 | 0.94 | USP2 (0.85) | NR3C1PGRUSP2CYP3A4LMNA | |
| SCHEMBL11586079 | 0.93 | NR3C1 (0.74) | NR3C1PGRUSP2CYP3A4LMNA | |
| SCHEMBL11586080 | 0.93 | NR3C1 (0.74) | NR3C1PGRUSP2CYP3A4LMNA | |
| Alclometasone Dipropionate SCHEMBL29459697 | 0.92 | PGR (1.00) | NR3C1PGRUSP2CYP3A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090012051-A1 | EXTERNAL PREPARATION | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2009-01-08 | — | — | US | claimed |
| US-20070287689-A1 | Therapeutic And/Or Preventive Agents For Chronic Skin Diseases | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-12-13 | — | — | US | claimed |
| EP-1810692-A1 | REMEDIES/PREVENTIVES FOR CHRONIC SKIN DISEASE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-07-25 | — | — | EP | claimed |
| US-6277834-B1 | ADMINISTERING TO PATIENT A DOSAGE OF A SYNERGISTIC ADJUVANT PHOSPHODIESTER COMPOUND TO REDUCE NEEDED DOSAGE OF ADRENOCORTICAL HORMONE | SENJU PHARMACEUTICAL CO. LTD. (JP) | 2001-08-21 | — | — | US | claimed |
| EP-1086698-A1 | AGENTS FOR RELIEVING SIDE EFFECTS OF ADRENAL CORTEX HORMONE | Senju Pharmaceutical Co., Ltd. (JP) | 2001-03-28 | — | — | EP | claimed |
| JP-8053354-A | — | — | None | — | — | JP | disclosed |
| WO-2024133513-A1 | COMPOSITION AND PRODUCTS COMPRISING AN ANTIBIOTIC AND A GLUCOCORTICOID FOR TREATING MASTITIS | VIRBAC (FR) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024080311-A1 | GENE INTRODUCTION METHOD, GENE THERAPY METHOD, AND TISSUE REGENERATION METHOD | 栗田 昌和 | 2024-04-18 | — | — | WO | disclosed |
| WO-2024071398-A1 | ABHD6 ANTAGONIST | 小野薬品工業株式会社 | 2024-04-04 | — | — | WO | disclosed |
| US-20240083899-A1 | PURINONE DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2024-03-14 | — | — | US | disclosed |
| US-11897885-B2 | Purinone derivative hydrochloride | ONO PHARMACEUTICAL CO., LTD. (JP) | 2024-02-13 | — | — | US | disclosed |
| US-20240016818-A1 | NOVEL USE OF GLUCOCORTICOIDS FOR THE TREATMENT OF EPITHELIAL MICROBIAL INFECTIONS OF A FLUID CONTAINING ORGAN WITH A NATURAL EXTERIOR ORIFICE IN MAMMALS | VIRBAC (FR) | 2024-01-18 | — | — | US | disclosed |
| US-6432431-B1 | GEL PATCHES CONTAINING CROTAMITON, CURING AGENTS, NONIONIC SURFACTANTS AND STEROLS ON NON-WOVEN FABRIC SUPPORTS HAVING AIR PERMEABILITY AND STORGE STABILITY; USED FOR ECZEMA, DERMATITIS AND ATOPIC DISEASES | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2002-08-13 | — | — | US | disclosed |
| US-6277834-B1 | ADMINISTERING TO PATIENT A DOSAGE OF A SYNERGISTIC ADJUVANT PHOSPHODIESTER COMPOUND TO REDUCE NEEDED DOSAGE OF ADRENOCORTICAL HORMONE | SENJU PHARMACEUTICAL CO. LTD. (JP) | 2001-08-21 | — | — | US | disclosed |
| EP-1097712-A1 | STEROID-CONTAINING CATAPLASMS AND PROCESS FOR PRODUCING THE SAME | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2001-05-09 | — | — | EP | disclosed |
| EP-1086698-A1 | AGENTS FOR RELIEVING SIDE EFFECTS OF ADRENAL CORTEX HORMONE | Senju Pharmaceutical Co., Ltd. (JP) | 2001-03-28 | — | — | EP | disclosed |
| US-6207184-B1 | PLASTER COMPRISING BACKING, ADHESIVE PASTE, COPOLYMER AND CROSSLINKING AGENT | SSP CO., LTD. (JP) | 2001-03-27 | — | — | US | disclosed |
| EP-1077066-A1 | PREVENTIVES/REMEDIES FOR SKIN DISEASES | Showa Denko Kabushiki Kaisha (JP) | 2001-02-21 | — | — | EP | disclosed |
| EP-0965626-A1 | Hydrophilic adhesive masses | SSP Co., Ltd. (JP) | 1999-12-22 | — | — | EP | disclosed |
| JP-H0853354-A | AQUEOUS PLASTER FOR DERMATOSIS | HISAMITSU PHARMACEUT CO INC | 1996-02-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11897885-B2 | Purinone derivative hydrochloride | BTK, P2RY1, P2RY13 | NR3C1 1906/4885PGR 599/4885USP2 3695/4885 |
| US-20090012051-A1 | EXTERNAL PREPARATION | CYP4A11, CYP46A1, CYP11B2 | NR3C1 556/4885PGR 2297/4885USP2 2116/4885 |
| US-20070287689-A1 | Therapeutic And/Or Preventive Agents For Chronic Skin Diseases | PDE4A, PDE3B, PDE2A | NR3C1 62/4885PGR 1575/4885USP2 2609/4885 |
| US-20240083899-A1 | PURINONE DERIVATIVE | BTK, KIT, SYK | NR3C1 1166/4885PGR 634/4885USP2 2527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.